Lisa Taxin, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 120 S York Rd, Hatboro, PA 19040 Phone: 215-441-0111 |
News Archive
Ebola and Marburg filovirus disease outbreaks have typically occurred as isolated events, confined to central Africa.
St. Jude Medical, Inc., a global medical device company, today announced regulatory and reimbursement approval from the Australian Therapeutic Goods Administration of its Brio™ deep brain stimulation system for treating the symptoms of Parkinson's disease.
PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that it has chosen bileduct cancer as the next indication for the use of its PCI (photochemical internalisation) localised cancer therapy. In this indication PCI Biotech's proprietary photosensitiser Amphinex® will be used in combination with the generic cytotoxic agent gemcitabine. The aim is to start the clinical Proof of Concept study within end of 1H 2013.
Researchers report a newly identified genetic variation that is linked to higher incidence of prostate cancer in African American men.
Results of a new study found that the investigational triple combination therapy of olmesartan medoxomil (OM), amlodipine besylate (AML), and hydrochlorothiazide (HCTZ) demonstrated significantly greater mean reductions at week 12 in blood pressure (37.1/21.8 mm Hg versus 27.5 to 30.0/15.1-18.0 mm Hg LS Mean Reductions, P< 0.0001), as compared to corresponding dual combination therapy (dual components).
› Verified 2 days ago